Last reviewed · How we verify

NCT07042399

Self-care Behaviors of Type 2 Diabetes Mellitus Patients

Recruiting now Last updated 29 June 2025
What this trial tests

trial in Type 2 Diabetes in 300 participants. Currently enrolling.

Timeline
1 March 2024
Primary endpoint
31 May 2027
31 May 2027

Quick facts

Lead sponsorUniversity of Milano Bicocca
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment300
Start date1 March 2024
Primary completion31 May 2027
Estimated completion31 May 2027
Sites2 locations across Italy

Conditions studied

Sponsor

University of Milano Bicocca

Who can join

18 and older, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to explore the experience of the chronic disease, with a particular focus on self-care, in adults with type 2 diabetes mellitus. The main questions it aims to answer are: * what is the association between self-care and glycated hemoglobin over time? * what are participants' clinical and sociodemographic characteristics influencing self-care behaviors? Participants' socio-demographic and clinical data will be collected by medical records and, at the beginning or at the end of the clinical standard outpatient visit, they will be asked to complete study questionnaires. The results of this study could be helpful in providing quality assistance, improving resource consumption, and reducing the onset of complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

Other University of Milano Bicocca trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07042399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing